- Details
- Last Updated: 11 February 2009 11 February 2009
luptatin henibh erostrud tet wiscil in ute facipis nostio odolore tat dunt am dit iure ting estionullam, volenis nulla consecte delesectet acidunt nulla alit, con eumsan ut illaor am vel inim dolore mod et nonsecte dolore vullaore magna faccum duis nim dunt nonse et venibh el dolutpat. luptatin henibh erostrud tet wiscil in ute facipis nostio odolore tat dunt am dit iure ting estionullam, volenis nulla consecte delesectet acidunt nulla alit, con eumsan ut illaor am vel inim dolore mod et nonsecte dolore vullaore magna faccum duis nim dunt nonse et venibh el dolutpat. luptatin henibh erostrud tet wiscil in ute facipis nostio odolore tat dunt am dit iure ting estionullam, volenis nulla consecte delesectet acidunt nulla alit, con eumsan ut illaor am vel inim dolore mod et nonsecte dolore vullaore magna faccum duis nim dunt nonse et venibh el dolutpat.
Notice about names
The Massachusetts ME/CFS & FM Association would like to clarify the use of the various acronyms for Chronic Fatigue Syndrome (CFS), Chronic Fatigue & Immune Dysfunction Syndrome (CFIDS) and Myalgic Encephalomyelitis (ME) on this site. When we generate our own articles on the illness, we will refer to it as ME/CFS, the term now generally used in the United States. When we are reporting on someone else’s report, we will use the term they use. The National Institutes of Health (NIH) and other federal agencies, including the CDC, are currently using ME/CFS.
Massachusetts ME/CFS & FM Association changed its name in July, 2018, to reflect this consensus.